drugset / Trial / NCT00885703

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

NCT00885703

RandomizedParallel-groupOpen-labelTreatment

Summary

Cryptococcal meningitis (CM) is an infection of the membranes covering the brain and spinal cord, caused by the fungus Cryptococcus neoformans. CM most often affects people with compromised immune systems, like those with advanced HIV infection. This study explored the safety, tolerability, and therapeutic effect of a new treatment regimen with high-dose fluconazole for management of CM in HIV-infected patients.

Timeline

Start
2010-04-16
Primary completion
2017-01-12
Completion
2017-01-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amphotericin B Unknown 0.7 mg/kg Intravenous
Comparator Amphotericin B Unknown 1 mg/kg Intravenous
Subject Fluconazole Small molecule 1200 mg Oral
Subject Fluconazole Small molecule 1600 mg Oral
Subject Fluconazole Small molecule 2000 mg Oral